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Abstract 
Multiplexed and Reiterative Detection of Protein Markers in 
Cells using Dynamic Nucleic Acid Complexes 
by 
Dzifa Yawa Duose 
The diagnosis, staging and clinical management of cancer and other diseases is 
becoming increasingly reliant upon the identification and quantification of molecular 
markers as well their spatial distribution in histological samples. Yet, due to spectral 
overlap of dyes and the inability to remove probes without affecting marker integrity, 
immunohistological methods are limited by the number of markers that can be examined 
on a single specimen resulting in loss of information that could be vital to diagnosis or 
treatment. 
This dissertation describes the development and characterization of an erasable 
multi-color imaging technology capable of detecting large numbers of molecular markers 
on a single biological sample. The system consists of (1) 'targets', which are single or 
partially hybridized DNA strands conjugated to a protein of interest for biomarker 
recognition in cells, and (2) multi-strand, fluorophore-containing DNA 'probe 
complexes' that react with the DNA portion of the target in a sequence dependent fashion 
to create fluorescent reporting complexes. The addition of a quencher-bearing ssDNA 
displaces the target's DNA strand to effectively remove the dye from the marker so that 
the sample can be re-imaged for other markers with minimal interference from prior 
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rounds of labeling. Orthogonal DNA sequences and spectrally-separated dyes can be used 
to create multiple, unique target/probe pairs that associate specifically and can be imaged 
in parallel. 
The overall utility of this technology depends on high specificity of targets to 
respective probe complexes, highly efficient labeling and erasing to ensure that 
fluorescent signals can be used to fully quantify target abundance without the interference 
of signals from previous rounds of labeling, and short reaction times to allow for multiple 
rounds of processing on the same sample without loss of integrity. Based on the above 
criteria, three classes of probes were designed and their structure-function relationships 
elucidated to determine the contributions of complex size, free energy differences 
between intermediate states, and strand displacement on labeling and erasing kinetics and 
efficiencies on cells. 
A comparison of the kinetics of the labeling and erasing reactions for the three 
different constructs showed that reaction efficiencies depend less on calculated net free 
energy change than on the engineered state of the complex during the strand 
displacement reaction (i.e., the type of strand displacement reaction it participates in). 
This new paradigm in probe design allowed the system to meet its design goals, 
potentially increasing the diagnostic power of individual histological specimens and 
opening the door to more sophisticated analyses of cell phenotype and its functional 
relationship to disease. 
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Chapter 1 
1.1. Overview 
The diagnosis, staging and clinical management of cancer and other diseases is 
becoming increasingly reliant on the identification and quantification of phenotypic 
indicators, called 'biomarkers', in histological samples. However, immunohistological 
methods remain substantially restricted by the fact that only a few biomarkers can be 
examined on a single biological sample. This is because many fluorescent dyes possess 
significant overlap in their excitation and emission spectra, and consequently cannot be 
completely distinguished using standard fluorescence microscopy methods. Furthermore, 
the immunoreactions used to label protein biomarkers are typically irreversible, 
prohibiting the removal or exchange of fluorescent reporters within a sample. The use of 
more than one specimen can circumvent this problem in some cases, but whenever 
heterogeneity across the specimens from a tissue confounds its characterization or is of 
central importance, diagnostic information is lost. In addition, vital information that can 
be derived from the spatial distributions of molecular marker levels in histological 
samples is lost when multiple specimens are used. This key deficiency compromises 
many analyses, and often prevents one from extracting the maximum amount of 
information from a clinical biopsy, particularly when samples are precious and their sizes 
are limited. 
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The goal of this project was to surmount this problem by developing and 
characterizing an erasable, multi-color imaging technology capable of detecting large 
numbers of molecular markers on a single biological sample. The technology utilizes 
dynamic nucleic acid complexes as probes for the selective coupling and removal of 
fluorophores to and from biomarkers via strand displacement mechanism (i.e. the 
selective exchange of single oligonucleotide strands between complexes of DNA). The 
system consists of (1) 'targets', which are ssDNA or partially hybridized oligonucleotide 
strands conjugated to a protein of interest for biomarker recognition in cells, and (2) 
multi-strand, fluorophore-containing DNA 'probe complexes' that react with the DNA 
portion of the target in a sequence dependent fashion via a toehold mediated strand 
displacement reaction to create fluorescent reporting complexes. The removal of the 
fluorophore (erasing step) follows via the addition of a quencher-bearing single or 
partially hybridized DNA complex that displaces the target's DNA strand to effectively 
remove the dye from the marker so that the sample can be reused to detect other markers 
with minimal interference from prior rounds of labeling. By combining dynamic DNA 
complexes that operate independent of one another with spectrally-separated dyes, 
multiple and unique target/probe pairs can be created that associate specifically and can 
be imaged in parallel. 
In order to successfully employ this technology for reiterative, multiplexed 
molecular biomarker imaging, the design must meet the following criteria; high 
specificity of targets to respective probe complexes; efficient labeling and erasing to 
ensure that fluorescent signals can be used to fully quantify target abundance without the 
interference of signals from previous rounds of labeling, and short reaction times to allow 
for multiple rounds of processing on the same sample without loss of sample integrity. To 
meet these goals three classes of probes were designed and their structure-function 
relationships elucidated to determine the contributions of complex size, free energy 
differences between states, and strand displacement on labeling and erasing kinetics and 
efficiencies on cells. 
1.2. Chapter Summaries 
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This dissertation describes the development and characterization of an 
erasable multi-color imaging technology capable of detecting large numbers (several 
tens and potentially hundreds) of molecular markers on a single sample termed 
Multiplexed (multi-color) and Reiterative Molecular Biomarker Imaging (MRMBI). 
This technology utilizes dynamic nucleic acid complexes (i.e. DNA complexes that 
take advantage of non-equilibrium dynamics of DNA hybridization) as probes to 
detect molecular markers (biomarkers) on cells and tissues via the selective coupling 
and removal of fluorophores to and from these markers. It demonstrates that dynamic 
DNA probes can facilitate multiplexed and reiterative fluorescent labeling reactions 
on specific intracellular proteins, and should increase the diagnostic power of 
individual histological examinations thereby opening the door to more sophisticated 
analyses of cell phenotype and its functional relationship to disease. 
Chapter 2 provides background and motivation for this work and briefly describes 
the importance of immunohistochemical/immunocytochemical techniques to disease 
diagnostics and prognosis as well as the need for erasable multiplexed fluorescence based 
immuno-based analyses. Additionally, this chapter provides an overview and the 
limitations of the current technologies available for in situ multiplexed marker imaging 
on a single sample. The chapter concludes with a summary of MRMBI technology and its 
mechanism of operation. 
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Chapter 3 details the design principles behind the use of dynamic nucleic acid 
complexes for Multiplexed and Reiterative Molecular Biomarker Imaging. It describes 
the design and characterization of several dynamic nucleic acid complexes as MRMBI 
probes in solution and on immobilized surfaces using a microarray platform. The 
selectivity and effectiveness of these probes in labeling their respective immobilized 
markers is also evaluated. In addition, the feasibility and utility of these probes for 
erasable and multiplexed imaging is assessed. Finally, the use of dynamic DNA 
complexes as imaging probes to reiteratively image targeted molecular markers in fixed 
cells is demonstrated. 
Chapter 4 provides an assessment and comparison of three different classes of 
imaging probes (probe constructs) to elucidate the contributions of complex size, free 
energy differences between states and strand displacement reactions on the labeling and 
erasing efficiencies on fixed cells. The kinetic rates of reaction of the three classes of 
imaging probes are compared to their calculated net free energy of reaction to determine 
which factor results in a more efficient and effective probe design. The chapter concludes 
with the development of an optimized dynamic nucleic acid probe system based on the 
results obtained from the characterization of the three probe constructs with short reaction 
times, non-prohibitive cost of production, highly efficient labeling and effective erasing 
steps. 
Chapter 5, the concluding chapter, provides a summary of the development and 
characterization of dynamic nucleic acid complexes as imaging probes for erasable 
multicolor imaging of molecular biomarkers in cells. The implications of the results 
obtained from this work and its applicability is discussed. The chapter concludes by 
providing a brief summary of results from on-going experiments that give new insights 
into the applicability of MRMBI to expanding the utility of immunofluorescence 
imaging. 
7 
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Chapter 2 
Background 
This chapter provides background and motivation for this work and briefly describes the 
importance of immunohistochemicallimmunocytochemical techniques to disease 
diagnostics and prognosis as well as the need for erasable multiplexed fluorescence based 
immuno-based analyses. Additionally, this chapter provides an overview and the 
limitations of the current technologies available for in situ multiplexed marker imaging 
on a single sample. The chapter concludes with a summary of Multiplexed and 
Reiterative Molecular Biomarker Imaging technology and its mechanism of operation. 
2.1. Motivation 
In recent years, tremendous strides have been made in the molecular characterization 
of malignant and non-malignant diseases in human and the signaling pathways 
underlying their evolution and progression. 1-2 A variety of technologies now make it 
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possible to profile molecular alterations associated with these conditions, including those 
that assess changes in genetic features (e.g., DNA copy number, chromosome 
translocations, mutations), epigenetic changes (e.g., chromatin methylation, acetylation, 
imprinting), gene expression changes, alternative transcripts, regulatory molecules (e.g., 
microRNAs, non-coding RNAs), protein changes (levels, posttranslational modifications, 
cellular localization, interaction partners), as well as metabolic states2-6. The 
identification of disease-associated changes through molecular and cellular analyses in 
tissues can be vital for cancer diagnosis, prognosis, and for monitoring patient responses 
to various treatments (i.e., intermediate, surrogate endpoints) during clinical trials,3-4 
thereby providing opportunities for the personalization and clinical management of 
cancer. 5-7 
While there are increasing efforts to develop methodologies for measunng 
molecular markers through non-invasive means (e.g., serum analysis, surface tissue 
swabs, molecular imaging)8-9 and through sensitive, high-throughput technologies (e.g., 
protein lysate arrays,IO-11 phosphorylation chromatography12), immunohistological 
analysis remains an invaluable technique that allows spatially-dependent changes in 
molecular marker levels within cells and tissues to be detected. 
Immunohistological analysis offers advantages over bulk analyses, since it allows the 
spatially dependent expression patterns of RNA and proteins to be delineated in cells and 
tissues. Several antibody and nucleic acid-based fluorescent probe technologies have 
been developed for marker imaging and the sensitivity of these probes has been 
continually improved13-15. Yet, many contemporary cytological studies now require 
increasingly comprehensive molecular pathway analyses to characterize the network-
level properties of cells and resolve functional relationships between cell phenotypes and 
their tissue distribution I6-18. In such cases, the number of markers one seeks to examine 
can easily exceed the number of probes that can be used simultaneously for detection due 
to the spectral overlap of the reporting dye molecules. Thus, various biological studies 
stand to benefit from methods that allow a greater number of molecular markers to be 
visualized on the same tissue sample so that any correlations between their distributions 
might also be analyzed, but immunohistology remains substantially limited in this 
respect. 
2.2. The need for multiplexed immuno-based imaging techniques 
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Immunofluorescence is a technique that exploits the specificity of antibody-antigen 
binding to detect specific molecular markers in cells and tissues, providing clinically 
relevant information for early detection, diagnosis, prognosis, and assessment of 
responsiveness to intervention. Because Immunofluorescence requires fluorophores for 
the visualization of markers, the spectral overlap of these fluorophores and the ability to 
separate them well from one another dictates the number of markers that can be analyzed 
on the same sample. Although there are several dyes whose peak excitations and 
emissions span from the UV (-300nm) to the far red (-800nm), the breadth of these 
spectra (-200 - 300nm) generally permits evaluation of only three markers per sample. 
Spectral de-convolution techniques make it possible to increase this number (7 to 10 
markers can be detected within the cells or tissues),19-21 but these capabilities are still 
insufficient for many applications. For such applications, multiple samples can be used to 
image different molecular markers using the same dyes,22 but unfortunately many tissue 
biopsies are small, limiting the number of sample tissue sections that can obtained. 
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For example, in a recent chemoprevention trial at M. D. Anderson Cancer Center 
involving the use of erlotinib (a tyrosine kinase inhibitor targeting EGFR) to prevent oral 
cancer development in high risk individuals,23 our collaborator Dr. Hittelman and fellow 
researchers were interested in examining multiple molecular markers (e.g., EGFR status, 
ERK status, cyclin Dl isoforms, proliferation markers, E-cadherin, vimentin, pSrc, 
TGFa, caspases, FHIT, hTERT, STAT3 status, pAKT, COX2, etc) associated with EGFR 
pathway. Even though comprehensive analyses of all of these markers would have been 
helpful for determining cancer risk and the impact of EGFR targeting on premalignant 
oral tissue, the actual markers that were evaluated had to be cut down and prioritized 
because the oral biopsies that were available were small. 
Many types of studies are restricted substantially by the need for parallel tissue 
sections for detection of multiple molecular markers, particularly those that rely on 
analyses of different markers within the same cells. For example, the phosphorylation of 
proteins at different amino acid positions can reflect their activation state, and 
relationships between these post-translational modifications and spatially-dependent 
expression patterns of proteins within cells and tissues can have important 
pathophysiologic implications.24 Optimally, these examinations would all be made on the 
same cells so that marker distribution variations between cells would not cloud the 
assessment. Other types of analyses are simply not possible when multiple samples are 
examined, especially those that focus on examining rare cells such as stem cells and 
tumor initiating cells also known as cancer stem cells (Figure 2.1) 21. The identification 
of such rare cells in the tissue implicitly requires the simultaneous use of several markers 
because of heterogeneity in tissue sections and in the case of stem cells (cancerous or 
not), information about the spatial localization of these multiple markers are important. 
Without multiplexed imaging technologies, it is not possible to expand the set of markers 
assayed, and our ability to characterize these rare cells will remain limited. The current 
approaches used in identifying tumor initiating cells (cancer stem cells) are discussed 
below, as well as how advances in multiplexed imaging technologies will facilitate their 
detection. 
Figure 2.1 : Tissue section of a H460 lung tumor xenograft21 • 
Tumor bearing animals were pulse treated with IdUrd (green label) 10 days earlier to 
mark the DNA of replicating tumor cells and with ClrdUrd (red label) just prior to tumor 
harvest. The slides were counterstained with DAPI to mark the nuclei. The cells with 
green stain are the long label retaining cells and are believed to include the dormant 
"cancer stem cells" that stopped proliferating early during tumor development. The red 
cells are the progenitor cells that continue to proliferate as the tumor enlarges 
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2.2.1. Example Application: Cancer Stem Cell Identification 
Multi-color immunohistological analysis is essential in the identification of rare 
cells such as tumor initiating cells (or cancer stem cells), which can constitute about 0.1 
to 1 % of a cancerous tumor,25 are suggested to be resistant to radiation therapy and have 
been implicated in the recurrence of cancer after radio-chemotherapy 26-27. Identification 
of these cells not only increases our understanding of the biology of cancers, it also aids 
in the development of therapeutic strategies that target these cells thereby improving 
treatment outcomes. 
In contrast to many other cell types24, there is currently no single biomarker 
available that can be used to detect these cells; rather, their identification relies on the 
presence and/or absence of a combination of multiple cell surface markers,2s, signaling 
pathway indicators and stem cell niche adhesion molecules involved in stem cell 
activation and mobilizations27. The need to use these markers in combination is driven, in 
part, by the fact that some of them are prevalent in normal cells, making their individual 
diagnostic power weak. For example, in the detection of breast cancer tumor initiating 
cells, Al Hajj et al25. labeled suspensions of tumor cells with antibodies specific for the 
lineage markers CD2, CD3, CDlO, CDI6, CDI8, CD31, CD64 and CDl40b and used 
fluorescence activated cell sorting (FACS) to separate lineage positive cells from lineage 
negative cells. 
The cells were further probed with the cell surface markers ESA, CD44 and 
CD24. Cells with various combinations of these markers were isolated by flow cytometry 
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and implanted into NOD/SCm mice fat pad. Al Hajj et al25 found that cells that were 
lineage negative, CD24 negative but ESA and CD44 positive exhibited the stem-like 
ability to form tumors that contained heterogeneous mixture of non-tumorigenic and 
tumorigenic cells similar to those in the original tumor (Figure 2.12). 
d Non-Tumorigenic 
e .-----------------~ 
Tumorigenic 
Figure 2.2: Identification of tumorigenic breast cancer cells. 
Histology from the CD24+ injection site (a; x20 objective magnification) revealed only 
normal mouse tissue, whereas the CD24-/low injection site (b; x40 objective 
magnification) contained malignant cells. (c) A representative tumor in a mouse at the 
CD44+CD24-/lowLineage- injection site, but not at the CD44+CD24+Lineage-
injection site. T3 cells were stained with Papanicolaou stain and examined 
microscopically (xl00 objective). Both the nontumorigenic (d) and tumorigenic (e) 
populations contained cells with a neoplastic appearance, with large nuclei and prominent 
nucleoli. 
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The flow cytometer is inadequate for use in clinical settings where biopsied 
samples are used because of the need for large sample sizes in analyses. In addition, only 
cells in suspension can be used in flow cytometry, a criteria that results in loss of spatial 
information critical in ascertaining niche contributions. 
In view of the fact that, the identification of cancer stem cells in tissue implicitly 
requires the simultaneous use of several markers, the availability of technologies that 
allow the successive and/or direct detection of a plethora of markers in a single clinical 
sample will greatly facilitate the understanding of cancer stem cells and also help to 
provide more targeted therapies.25 
2.3. Current Technologies 
A number of significant technical issues must be addressed to perform 
multiplexed marker analyses on a single specimen28• There are two main approaches to 
addressing this limitation: the first focuses on improving microscope optics and 
developing new dyes to increase the number of spectrally-separated imaging channels 
that can be used simultaneously; the second approach is to develop a technique that 
would allow the serial use of the same "channel" for multiple markers. Both approaches 
face unique challenges to their application to multiplexed marker identification via 
immuno-based methods. 
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2.3.1. Development of optics and dyes for multiplexed marker imaging 
In recent years, numerous organic and inorganic dyes have been developed that 
span a good proportion of the electromagnetic spectrum (from UV to IR),29 -32 providing a 
plethora of spectrally distinct dyes available for multicolor imaging. However, these dyes 
frequently have broad emission spectra resulting in signal spill over (crosstalk) with dyes 
that have overlapping emission spectra. Quantum dots (QD) outperform single-molecule 
dyes because of their intrinsically high quantum efficiencies, photostabilities32-34, and 
narrow emission spectra. For immuno-based detection, antibodies are conjugated to the 
surface of a quantum dot prior to being used to label molecular markers. The conjugation 
of antibodies on quantum dot surface, results in an increase in size of the quantum dot as 
well as an unorganized distribution of antibodies on QD's. Thus, despite its numerous 
attributes, QD-based labeling approaches in many clinical applications34 have had limited 
success in part due to the large size of QDs (compared to antibodies) and the unorganized 
presentation of antibodies on their surface, which affects the efficiency and selectivity of 
antibodies. Regardless, both QD's and organic/inorganic dyes need to be spectrally 
separated with optical filters to ensure minimal crosstalk between channels, which limits 
the number of colors that can be simultaneously probed to about 3 or 4. This is because 
optical filters that can adequately separate the excitation and emission spectra of 
fluorophores with overlapping spectra may decrease the signal strength or eliminate 
signal from one fluorophore because of its spectral bandwidth. 
This issue is being addressed through the development of hyperspectral imaging 
microscopes that have the ability to de-convolve spectrally overlapped dyes into their 
unique components when used in imaging applications, and have been used to detect up 
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to 10 different markers on a single sample35• These instruments are often expensive and 
not widely available, so alternative approaches that do not rely heavily on optics must be 
developed to complement advances in microscope technologies. The number of markers 
that can be evaluated on an individual biological sample could be increased if it were 
possible to remove fluorescent probes from cells such that new markers could be labeled 
and detected using the same fluorescent reporting molecules. Sequential analysis of 
biological specimens takes advantage of current fluorophores and epifluorescent 
microscopes to detect multiple markers on a singular sample by re-probing the same 
sample multiple times. Sequential analysis when combined with hyperspectral imaging 
microscopes has the potential to greatly increase the number of markers evaluated on a 
single biological sample. 
2.3.2. Sequential analysis of biological specimen for multiplexed marker imaging 
Re-Iabeling of a sample can be accomplished in two ways, either by removing the 
antibody (and the dye in doing so), or by removing the dye alone. Sequential removal of 
antibody probes has been accomplished by treating samples with caustic chemicals prior 
to the application of the next set of antibody probes36-37. Alternatively, high temperatures 
have been used to inactivate antibodies prior to the application of the next set of antibody 
probes38. These harsh methods have limited utility because they tend to compromise both 
the molecular-level epitopes targeted by antibodies and the larger scale morphological 
features of cells and tissues. 
One method of "removing" dyes involves iterative re-staining where the same 
fluorophore is used to label and re-Iabel different antigens on the same cell. Instead of 
physically removing the dyes, their signals are accounted for at each round of imaging 
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and removed from subsequent rounds during data processing. A laser scanning cytometer 
is required to track intensities from current and previous iterations of staining and to 
determine the fluorescence shifts from the subsequent labeling40. Due to the addition of 
dyes through sequential labeling, detection of low level signals is difficult; saturation of 
channels is a problem, and the addition of the same dye in subsequent imaging steps 
results in high background noise. 
An alternate method involves the bleaching of the fluorophores following each 
sequentiallabeling40. This could be done either through differential photobleaching, (i.e 
identifying different fluorophores based on their unique photostability signatures) 40 or by 
photo-destruction of fluorophores. Both approaches involve exposing the sample to laser 
irradiation for 10 mins or more, which can adversely affect sample integrity when 
performed multiple times. In addition, bleaching does not completely remove the signal 
from prior labeling, resulting in residual accumulation in subsequent processing steps that 
compromises analyses. Therefore, new approaches are needed for multiplexed molecular 
marker analyses of cells whereby the same sample can be probed and re-probed for 
multiple markers sequentially. 
2.4. The solution: Multiplexed and Reiterative Molecular Biomarker 
Imaging (MRMBI) 
Recent advances in the field of DNA nanotechnology have facilitated the creation 
of various dynamic DNA and RNA complexes that can function effectively as 
programmable logic gates41 -43, chemical amplifiers44-45, and reconfigurable molecular 
structures46. A key feature of these complexes is that, instead of classical hybridization 
reactions, they can operate via a process called strand displacement47 - the exchange 
oligonucleotides possessing partially or fully identical sequences between different 
thermodynamically-stable multi-strand complexes (examples are shown in Figures 1 and 
2). Using this mechanism, long nucleic acid complexes possessing many matched base 
pairs can be hybridized and de-hybridized multiple times at room temperature. Since 
strand displacement reactions are sequence dependent, and tend to be more sensitive to 
base mismatches than classical hybridization reactions48, different dynamic complexes 
can be designed to operate independently of one another, or, alternatively, integrated into 
reaction networks that can perform complex computations that are programmed in 
oligonucleotide sequence49-50. Such capabilities now offer opportunities to create new 
classes of molecular probes for molecular-cell analyses51-52. 
The unique potential of dynamic nucleic acid complexes for molecular-cell 
analyses are beginning to be realized. Engineered RNA hairpin devices have been used 
as 'smart' therapeutic technologies that can both detect genetic disease indicators in vitro 
and, in response, produce double stranded oligonucleotide polymers that selectively 
trigger cell apoptosis53• Multiplexed (5-color) in situ detection of mRNA transcripts in 
fixed drosophila embryos has also been demonstrated52. 
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The goal of this project is to develop utilize dynamic nucleic acid complexes in 
the development of an erasable multicolor molecular marker analysis technology (termed 
multiplexed and reiterative molecular biomarker imaging) capable of detecting large 
numbers (several tens and potentially hundreds) of molecular markers on a single clinical 
sample. The system consists of (1) 'targets', which are single or partially hybridized 
DNA strands conjugated to a protein of interest for biomarker recognition in cells, and 
(2) multi-strand, fluorophore-containing DNA 'probe complexes' that react with the 
DNA portion of the target in a sequence dependent fashion to create chemically 
switchable fluorescent reporting complexes. The addition of a quencher-bearing ssDNA 
displaces the target's DNA strand to effectively remove the dye from the marker so that 
the sample can be re-imaged for other markers with minimal interference from prior 
rounds of labeling. The ability to control the switching of these complexes is made 
possible by the use a process known as strand displacement. This is the selective 
exchange of single or partially hybridized oligonucleotide strands possessing fully or 
partially identical sequences between different thermodynamically stable multi-strand 
complexes.47 
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Figure 2.3: DNA strand displacement mechanism. 
Domains 1,2 and 3 are complementary to domains 1 *,2* and 3* respectively. Domain 1 
is a toehold domain; Domains 2 and 3 are specificity domains (Top left); Domain 3 is a 
toehold domain; Domains 1 and 2 are specificity domains (Bottom left); Step by step 
illustration of strand displacement (Right). 
Figure 2.3 illustrates the strand displacement mechanism. Here domains 1, 2 and 3 are 
complementary to domains 1 *, 2* and 3*. Domains 2 and 3 are specificity domains because 
any base mismatch within their sequence will slow down the strand displacement reaction. 
The strand displacement reaction proceeds when the single stranded portion of complex 1 
(domain 1) serves as a toehold through which domain 1 * of the green strand (complementary 
domain) can latch on to and initiate the invasion of complex 1 and subsequently displace the 
blue strand in a sequence specific manner. This creates a new partially hybridized complex 
(complex 2) with an un-hybridized domain 3 which serves as a toehold that can facilitate 
another strand displacement reaction. 
Thus, the strand displacement mechanism allows DNA complexes to go through 
multiple states by being hybridized and un-hybridized numerous times at room 
temperature before equilibrium is reached. Strand displacement reactions are sequence 
dependent and more sensitive to base mismatches than classical hybridizations reactions48 
thus several dynamic DNA complexes can be designed to operate independent of one 
another and used to image different molecular markers simultaneously. 
By combining dynamic DNA complexes with self assembled DNA-conjugated 
antibodies, the project develops a new technology that utilizes the immunoreactivity of 
antibodies for antigen recognition and the strand displacement capabilities of dynamic 
DNA complexes for fluorophore exchange. This capability allows the same color 
fluorophores to be used reiterative1y, via multiple rounds of fluorescent microscopy, to 
detect different sets of protein markers as illustrated in Figure 2.4. Subsequently, much 
more comprehensive analyses of molecular marker levels can be performed since the 
spectral overlap of fluorescent dyes will no longer limit the number of molecular markers 
that can be visualized on individual samples using fluorescence microscopy. For this 
application, the strand displacement reactions driving the labeling and erasing of markers 
must be selective and efficient (high labeling and dye removal yields) to facilitate 
quantitative assessments of markers levels and to ensure residual signals left on a sample 
after an erasing step do not compromise subsequent markers analyses. 
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Figure 2.4: Multiplexed biomarker imaging via Multiplexed and Reiterative 
Molecular Biomarker Imaging. 
2.4.1. Adaptation of Entropy-driven DNA circuits for Multiplexed and 
Reiterative Molecular Biomarker Imaging 
The initial imaging probes were designed around a class of artificial biochemical 
circuits developed by Zhang et al54 . These circuits utilize simple DNA complexes as both 
designable catalysts and as substrates in biochemical reactions that involve the selective 
exchange and release of specific single-strands of DNA between reaction components. 
Individual reactions that make up these circuits are driven forward by configurational 
entropy: the number of components present in solution is increased as these reactions 
proceed to completion. 
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Figure 2.5: The adaptation of entropically driven circuit for MRMBI. 
This mechanism is optimal for biomarker imaging since these circuit designs do not 
depend on enthalpy-driven reactions to function (e.g., via a net increase in base-pair 
formation or conformational changes of engineered DNA complexes). These entropy-
driven reactions function robustly at ambient temperatures and in mild buffers (e.g., 20 
mM Tris, pH 7-8). Consequently, this technology will facilitate fluorophore reutilization 
while minimizing perturbations to the morphology and composition of cells and tissues. 
The artificial biochemical circuit adapted for multiplexed and reiterative molecular 
biomarker imaging is illustrated in figure 2.5. Adopting the nomenclature of Zhang et al 
54, the entropically driven circuits are composed of three main components: a single 
stranded catalyst strand (C), a partially hybridized three-strand DNA complex called the 
substrate (S), and a ssDNA fuel strand (F). DNA circuit reactions are initiated by the 
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binding of the catalyst strand to a 6 bp ssDNA domain at one end of the substrate called a 
'toe-hold' domain. The binding of the catalyst to the toehold domain results in the 
invasion of the substrate complex by the catalyst strand leading to the displacement of the 
'output strand' (01) within the substrate complex by the catalyst strand. This strand 
displacement reaction produces an intermediate state complex (IR) that now possesses a 
new, internal toe-hold composed of 4 unmatched base pairs. The circuit reaction cycle 
can then be completed via a second strand exchange reaction that is initiated by the 
binding of F to the toe-hold in IR. This reaction releases both the catalyst and a second 
substrate strand (02), and produces a single linear duplex called the waste complex (W). 
Thus the catalyst can engage in successive strand displacement reactions in the presence 
of a substrate complex to produce the intermediate reporting complex. 
To convert circuits into imaging probes, fluorescent dyes (Cy3 or Cy5) and quenchers 
(Iowa Black) were incorporated into the substrate complexes. These molecules are 
positioned within the substrate complex such that the displacement of output 01 by the 
catalyst strand produces an IR complex (reporting complex) that contains an unquenched 
fluorophore - which is the labeling reaction. The addition of a quencher-bearing fuel 
strand can then be used to selectively remove the fluorophore-bearing strands from the 
catalyst, resulting in a quenched duplexed waste complex - which is the erasing reaction. 
For biomarker recognition, the ssDNA catalyst strand is conjugated to a protein (ex. 
Antibody) that binds to biomarker of interest thus enabling its detection during the 
labeling step. In addition, the technology is amenable to the detection of a plethora of 
biomarkers so long as the catalyst can be conjugated to their respective ligands (antibody, 
mRNAetc). 
In conclusion, multiplexed and reiterative molecular biomarker imaging opens up 
the possibility to analyze the genomic and proteomic properties of whole cell populations 
on the single cell level. It also facilitates our understanding of complex processes in 
health and disease and could be an important tool for predictive and preventative 
medicine. 
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Chapter 3 
Multiplexed and Reiterative 
Labeling via DNA Circuitry12 
Fluorescence 
3.1. Introduction 
In this chapter we show that the dynamic DNA complexes designed by Zhang et 
aZ54 for use as an artificial biochemical circuit can be adapted to create erasable molecular 
imaging probes that can function at ambient temperatures and in mild, non-denaturing 
buffers (e.g., Tris-based buffers). Several dynamic DNA complexes are designed and 
characterized in solution and on immobilized surfaces using a micro array platform. The 
selectivity and effectiveness of these probes in labeling their respective immobilized 
markers is also evaluated. In addition, the feasibility and utility of these probes for 
1 This chapter has been published in the following journal article: Duose D. Y, Schweller R. M, 
Hittelrnan W. N and Diehl M. R, (2010) "Multiplexed and Reiterative Fluorescence Labeling via DNA 
Circuitry", Bioconjug. Chern. 21 (12), 2327-2331. 
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erasable and multiplexed imaging is assessed. Finally, the use of dynamic DNA 
complexes as imaging probes to reiteratively image targeted molecular markers in fixed 
cells is demonstrated. 
3.2. Materials and Methods 
3.2.1. DNA Circuit Design and Characterization 
Two of the dynamic DNA complexes (circuit 1 and 2) used in our experiments 
was taken directly from Zhang et az54 , the others were designed in-house. The strands for 
each catalyst, substrate and fuel (eraser) set were designed on a domain basis. The 
domains were designed according to their functionality. Toehold domains were designed 
to be short (4-lOnt) as this accelerated the initiation of strand displacement reactions. 
Specificity domains were designed to be thermally stable, and to function in a sequence 
specific manner. Complementary domains were designed to be complementary only to 
their respective specificity domains. First, random sequences with 40-50% GC content 
were generated for each domain, checked for secondary structure using rnFold55 and then 
altered by hand to remove bases that cause secondary structure. Next, the domains were 
concatenated together, rechecked for secondary structure and spurious bindings with 
rnFold55 . This process was repeated till a satisfactory strand was obtained that contained 
minimum secondary structure. 
Fluorophores and quenchers were incorporated into substrate complexes as shown 
in Appendix A. Strands outfitted with fluorophores or quenchers were purchased HPLC-
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purified. DNA complexes were formed via a thermal annealing procedure: strands were 
mixed together at a 1: 1 stoichiometry in T AE/Mg2+ buffer at a final concentration of 3 
llM. The temperature of this solution was then raised to 95°C and reduced to 25 °C over 
90 min. DNA complex formation was verified by 12% nondenaturing PAGE gel analyses 
using SYBR-Gold staining (Invitrogen). 
3.2.2. Conjugation of ssDNA catalyst with artificial protein (leucine zipper) 
Oligonucleotides were purchased from Integrated DNA Technologies (IDT) and their 
sequences are given in Appendix A. The recombinant target protein GFP-ZE, was 
designed with C-terminal leucine zipper (ZE) and 6x Histidine tag (6xHis) for 
purification using standard cloning procedures. Artificial proteins were labeled with 
catalyst DNA as described in reference 56. Briefly, the C-terminal cysteine of the 
polymers was reduced and covalently linked to the amine terminated single-stranded 
DNA catalyst using the hetero-bifunctional crosslinking reagent SMCC57 450llL of 10 
mg/ml protein in 8M Urea, pH 7.2 was added to 50llL of 400 mM TCEP (tris(2-
carboxyethyl)phosphine), and the pH was adjusted to 4.5. The C-terminal cysteine in the 
protein was reduced by incubating the reaction for 1.5 hours at 37°C. While incubating, a 
Nap-5 column was equilibrated with 10 mI of 8 M Urea. After incubation, 500 ilL of the 
reduced protein was added to the Nap-5 column to remove excess reducing agent, and 
eluted with 1 ml 8M Urea pH 7.2, yielding a final volume of 1 mI. Half an hour into the 
protein reduction reaction, the amine DNA was reacted with the NHS-ester of the sulfo-
SMCC by combining 100 ilL of amine-termined DNA (100 IlM), lOOIlL conjugation 
buffer (20 mM NaH2P04, 80 mM Na2HP04, 150 mM NaCI andl mM EDTA pH to 
7.3), and 60 ilL sulfo-SMCC (2 mg sulfo-SMCC/60 ilL DMF). This mixture was allowed 
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to react at 370C for Ihour. A second Nap-5 column was equilibrated with 10 ml IX PBS. 
After incubation, the DNA reaction was diluted by adding 240 ilL of conjugation buffer, 
and was then transferred to the Nap-5 column and eluted with 1 ml IX PBS, yielding a 
final volume of 1 ml DNA. The DNA and reduced protein volumes were then added in 
1: 1 ratio in microcentrifuge tubes, wrapped in foil, and agitated with a shaker for 2 hours 
at room temperature. The shaker was then moved to 4°C, and allowed to react overnight. 
The sample was then purified using FPLC with a Hi trap Q XL 5 mL column on a 1-
100% NaCl gradient over 12 CV in 20 mM tris buffer (pH 8.3). The fractions, identified 
by UV absorbance were collected and analyzed using an SDS-PAGE gel treated with 
Stains-All to verify the presence of both DNA and protein in the sample. Fractions 
containing the DNA/protein conjugate were combined, lyophilized, dissolved in 
TAE+ 12.5 mM Mg(OAC)2, aliquoted, and then stored at -20°C. 
3.2.3. Microarray Procedures 
The DNA micro arrays were printed on Vantage silyated aldehyde slides (CEL 
Associates) using SMP3 pins (ArrayIt) and a custom fabricated microcontact printer. 
Arrays were fabricated by spotting solutions of 3'-amine labeled C strands (10, 5, 1, 0.5, 
0.1, and 0.05 ~M stocks for gradient experiments and 2 ~M stocks for all others) in PBS 
(pH 6.6) containing 30% glycerol. Afterward, the slides were incubated in a humidity 
chamber for 6 h. Free aldehyde groups on the slides were then quenched for 5 min in a 
sodium borohydride solution (3: 1 PBSlEtOH 2.5% NaBH4). Slides were blocked for 2 h 
in 4x SSPE buffer (600 mM NaCl, 40 mM NaH2P04, and 5 mM EDTA) containing 0.1 % 
BSA, washed 3 times with 4x SSPE buffer with 0.1 % SDS, rinsed with milli-H20, and 
dried under nitrogen. 
Microarray labeling/activation and dye removal/deactivation reactions were 
performed using a static incubation procedure or with a hybridization station (TrayMix2: 
Arraylt) that provides active mixing of reagents over the slide. For static incubation, 
Gene frames (AbGene) were affixed over the arrays to create a reaction chamber 
containing 5 pmol substrate and OCI consumption complex in TAE w/Mg2+. The arrays 
were incubated overnight. The Gene frames were then removed and slides were washed 3 
times in 4x SSPE buffer, rinsed again in milli-H20, and dried under a nitrogen stream. 
Deactivation and reiterative labeling experiments were performed similarly by affixing 
new Gene frames to the slides and repeating the incubation procedure. Microarray 
analysis was performed using Image] (http://rsbweb.nih.gov.ezproxy.rice.edu/ijl). 
3.2.4. Cell Culture and Labeling 
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HeLa cells were cultured in an 8-chambered coverslips (Lab-Tek) for 24 h in 
DMEM supplemented with 10% FBS, 50 ~glmL penicillin, and 50 ~g/mL of 
streptomycin. For GFP labeling experiments, the media was replaced and the cells were 
transfected with GFP-ZE DNA using Fugene (Roche) transfection reagent under the 
manufacturer's protocol. 
To label cells, coverslips were washed once with PBS and fixed with freshly 
prepared 4% paraformaldehyde (PFA) in PBS pH 7.2 for 30 min. The cells were then 
washed twice for 2 min with PBS, permeabilized for 5 min with 0.2% Triton X-lOO, 
washed twice again with PBS, and stored overnight at 4 0c. Prior to circuit labeling 
experiments, the cells were washed again with PBS and then incubated for 2 h with a 
blocking solution (1 % BSA, I mg/mL denatured Herring sperm DNA, and 0.5 ~M polyT 
DNA in PBS). For GFP labeling experiments, the cells were also incubated with 400 nM 
of ZR-ELS6-Catl in PBS for 2 h. Excess polymer was then removed by washing twice 
with PBS prior to circuit-based labeling. 
Circuit labeling reactions were carried out by incubating the cells for 1.5 h with 
100 nM substrate complex and then washing twice with PBS for 2 min. Dye removal was 
performed similarly using 1 /lM fuel. Before imaging experiments, slides were washed 
twice with PBS and then mounted on a glass slide using rubber cement. 
3.2.5. Fluoresence Imaging and Analyses 
All images were collected using a Zeiss Axioplan epifluorescence microscope and 
are contrasted identically in each figure. Correlations between GFP and Cy5-circuit 
signals and Cy5 signals produced during sequential labeling of cells (aNi and ON2) were 
analyzed using a custom program written in Matlab. 
3.3. Results and Discussion 
An illustration depicting our use of entropically driven circuits as imaging probes 
is shown in Figure 3.1. Adopting the nomenclature of Zhang et al.54, these circuits are 
composed of three main components: a single-stranded "catalyst" strand (C), a three-
strand DNA complex called the "substrate" (S), and a "fuel" strand (F). 
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Figure 3.1: DNA circuit-based marker labeling and dye removal reactions. 
In the circuit reaction cycle, the binding of C to a 6 nucleotide "toehold" domain 
at one end of S initiates a strand displacement reaction that releases an "output" strand 
(01 ) and produces an intermediate-state complex (lR) that possesses a new, internal 4 bp 
toehold domain. The binding of F to this toehold then initiates a second strand 
displacement reaction that releases C from the IR complex and produces a "waste" 
product (W). To convert these complexes into imaging probes, catalyst strands can be 
appended to targeting agents that bind to specific molecular markers. The circuit 
substrates are modified by incorporating fluorescent dye (Cy3 or Cy5) and quencher 
(Iowa Black) molecules that are positioned such that the reaction of S with C results in an 
IR complex that contains an unquenched fluorophore . The dye-bearing strand within IR 
can then be removed from the marker and rendered inactive in the waste product by 
incubation with a modified F strand that carries a second quencher molecule. Overall, the 
use of quenched substrates and waste products should reduce background fluorescence 
resulting from potential nonspecific binding of either complex to a sample. Finally, we 
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note that, in contrast to prior work where C truly functioned as a catalyst54, marker 
labeling and removal in the present application is achieved by performing partial circuit 
reactions while using C for targeting. We therefore use the term catalyst only for 
continuity with previous reports. 
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Figure 3.2:Native PAGE gel displaying DNA circuit reaction products 
The lanes in the gel can correspond to: lane 1: 10 bp DNA ladder; lane 2: (S); lane 3: 
partial circuit reaction of Sand C that includes output 1 consumption; lane 4: full 
circuit reaction of S, C, and F; lane 5: partial reaction of Sand C that omits output 1 
consumption. In all lanes, [S] = [C] = [F] = [DC] = 200 nM. 
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For the labeling and erasing reactions to function efficiently, the formation of the 
reporting and waste complex respectively must go to completion. To evaluate the 
efficiency of the circuit-based labeling and dye removal reactions, we first examined 
distributions of product complexes that were formed upon incubations of Sand C, as well 
as S, C, and F via native PAGE-gel analyses (Figure 3.2).After a partial circuit reaction 
of S with C, the catalyst strand is bound to the IR complex through a total of 22 matched 
base pairs. This complex is therefore stable at room temperature and can be isolated on a 
gel. Yet, the free energy difference between Sand IR is small (t1G --0.4 kcallmol). As a 
result, the reaction of S and C, when performed using equimolar concentrations, results in 
an equilibrium distribution of circuit components possessing near-equivalent 
concentrations of S, IR, and free, "unlabeled" catalyst (Figure 3.2, lane 5). While this 
result is not optimal for marker labeling, this reaction can be driven forward by adding a 
second complex (OC1) that consumes (01) once it is liberated from S (boxed reaction in 
Figure 3.1). As demonstrated in other strand displacement systems58, the sequestration of 
01 shifts the eqUilibrium distribution of the reaction significantly toward the IR state 
(Figure 3.2, lane 3). Alternatively, this distribution can also be shifted using an excess of 
S relative to C, which should often be the case when labeling catalysts (markers) that are 
immobilized on a specimen. Nevertheless, the ability to drive strand displacement 
reactions forward through output sequestration will likely be useful for optimizing dye-
labeling kinetics or when local target concentrations within a sample are high. 
The removal of dyes from a sample via the reaction of IR and F constitutes an 
equally important step in our marker imaging procedure. Here, the use of three-strand S 
and IR complexes, as opposed to somewhat simpler two-strand complexes, allows dye-
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bearing strands to be displaced from the reporting IR complex without output 
sequestration (Figure 3.2, lane 4), since two strands (C and 02) must react 
simultaneously with final circuit product W for the reverse reaction W + 02 + C ~ IR + 
F to occur. Hence, the dye removal reaction is effectively irreversible. 
We next performed a series of DNA microarray experiments that were designed 
to evaluate the use of DNA circuit complexes as molecular imaging probes (Figure 3.3). 
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Figure 3.3: Concentration gradient of catalyst microarray. 
A catalyst microarray possessing a gradient of spot concentrations (using 10, 5, 1, 0.5, 
0.1, and 0.05 ~M stock solutions) that was first labelled and then erased via the sequential 
addition of S (top image) and a fuel strand (bottom image). Images are rendered as heat 
maps. Plots of the averaged intensity profile of the boxed regions for the labelling (black 
line) and dye removal (red line) reactions are shown, Average spot intensities can be 
approximated by the Langmuir equation (inset). 
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In these experiments, amine-modified C strands are arrayed on the surfaces of 
glass slides, and the reaction of S with C produces a fluorescent IR complex that is 
anchored to the slide surface and can be detected using a fluorescence micro array 
scanner. Analyses of arrays where a catalyst was printed at variable spot concentrations 
confirm that the IR complex of the circuit can function as a reliable reporter of the levels 
of immobilized catalyst (Figure 3.3). Here, spot intensity profiles can be approximated by 
the Langmuir adsorption equation, as is commonly found with DNA microarrays 59-60. 
Furthermore, after the same slide is incubated with a fuel strand, each spot disappears and 
cannot be detected over background autofluorescence signals of the slide (Figure 3.3, 
bottom left). 
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Figure 3.4.Reiterative Labeling of individual arrayed catalysts. 
The same catalyst strand was labelled (ON I), erased (OFF) and re-Iabelled (ON2) on the 
same slide. 
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Our micro array experiments also allowed us to demonstrate the use of DNA 
circuit probes for both multiplexed and reiterative marker labeling. We found that 
immobilized C strands can be labeled with dyes multiple times via sequential reactions of 
arrays with S, F, and then a second solution of S complexes (Figure 3.4). Each labeling 
reaction produced arrays possessing near identical spot intensities. 
We also demonstrated that multiple C targets could be labeled and/or erased 
simultaneously using multiple Sand F complexes in a single reaction step (Figure 3.5). In 
these experiments, five different C strands were printed both as mixtures of two strands 
and individually on the surface of the slide. The array was then reacted with two different 
substrate complexes (S l-Cy5 and S2-Cy3), yielding a spot pattern that corresponded 
directly to the positions of the printed catalysts (CI and C2). Subsequently, in a single 
incubation step, this pattern was erased with FI and F2, and a new spot pattern was 
generated through a reaction with a second set of substrates (S3-Cy5 and S4-Cy3); 
spotted lanes where C3 and C4 were printed appear in the scanned image. Throughout 
this procedure, the fifth printed catalyst strand of the array (C5) remains unlabeled in 
both scanned images. 
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Figure 3.5: Multiplexed and reiterative labeling of multiple DNA catalysts. 
The reactions performed on the arrays are indicated above each image. 
Thus, these experiments confirm that DNA circuitry can be used for multiplexed and 
reiterative imaging: two fluorescent dye molecules and two spectral channels of an 
imaging system are used to detect four distinct markers on the same sample. Importantly, 
all labeling and removal reactions in these assays were performed using mild processing 
conditions (room temperature and Tris buffer supplemented with 12.5 mM Mg2+). 
We next performed a series of imaging experiments that show DNA circuit 
complexes can be used to selectively label molecular markers on fixed and permeablized 
HeLa cells. Background circuit reactivity was first tested by incubating cell samples with 
a quenched S complex (100 nM) for 1.5 h. The resulting images show no discernible 
fluorescence signals and possess signal to background ratios of 1 (Figure 3.6), implying 
that the substrate complexes have exceptionally low background reactivity with cells. We 
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attribute this property to the high stability of the duplexed substrate complex, the 
enhanced sequence specificity of strand exchange over a classical hybridization 
mechanism61, and the ability to place dye and quencher molecules in close proximity to 
one another within the substrate complex. 
Figure 3.6 Determination of background circuit reactivity 
Bright field (BF) and fluorescence images of paraformaldehyde-fixed and permeablized 
HeLa cells reacted with a substrate complex that incorporates a Cy5 and a quencher 
(Iowa Black). 
To label markers on cells, we chose to target the DNA circuit complexes to a 
transfected and expressed green fluorescent protein construct (GFP-ZE) so that 
circuit labeling and dye removal efficiencies could be benchmarked directly against 
an internal standard ( 
Figure 3.7). The catalyst strand was coupled to the GFP using DNA-
conjugated artificial-protein-based polymers (ZR-ELS6-ssCat) that we have 
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previously developed for protein-DNA labelings6. These polymers associate with 
the GFP-ZE via a heterodimeric leucine zipper complex (ZEjZR: Ko _10-15 M). Thus, 
after incubating GFP-ZE transfected HeLa cells with ZR-ELS6-ssCat and then washing 
the samples to remove unbound polymer, GFP-ZE transfected cells can be labeled by 
a reaction of a circuit substrate complex that carries a CyS dye and a quencher . 
. 
C 
Figure 3.7: Targeting DNA circuit complex to GFP-ZE. 
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Figure 3.8: Circuit-based labeling of GFP-ZE transfected HeLa cells. 
(top) and intensity correlation analyses of GFP-ZE and DNA circuit (Cy5) signals 
(bottom). 
As seen in Figure 3.8, cells that were successfully transfected with GFP-ZE reacted with 
S to produce fluorescent signals in the Cy5 channel of the microscope. While cells that 
were not transfected did not exhibit fluorescence, clear linear correlations are observed 
between GFP-ZE and circuit labeling intensities, yielding a correlation coefficient r = 
0.95. 
We also tested whether molecular markers could be labeled multiple times on a 
single sample of cells without loss of fluorescence signal intensities (Figure 3.8). After a 
first round of circuit labeling and imaging, fuel strands were added to remove Cy5 dyes 
from a sample of GFP-ZE transfected cells. As in our microarray experiments, dye 
removal reactions are found to be efficient and yield signal to background ratios of 1. In 
addition, the transfected cells could be labeled and imaged a second time by incubating 
the sample with a fresh solution of substrate. Bright field imaging showed that a small 
portion of the cells detached from the slide surface during our manual washing and 
coverslip mounting procedures. Nevertheless, GFP and Cy5 signals remain highly 
correlated on a pixel-by-pixel basis after both rounds of fluorescence labeling (r > 0.95). 
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Figure 3.9: Reiterative circuit labeling of GFP-ZE transfected cells. 
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Sequential images of GFP-ZE transfected cells where circuit complexes were used to 
label (ONI), erase (OFF), and relabel (ON2) the same sample of HeLa cells are shown. 
The pixel intensities in both Cy5 images (Cy5/0NI and Cy5/0N2) are linearly 
correlated; fitted slope = 1.1, r = 0.92. 
Furthermore, strong correlations were found between cell images collected after 
the first and second dye labeling reactions are performed (i.e., between the ONI and ON2 
images in 
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Figure 3.9). The Cy5 intensities of both images are linearly correlated and can be 
approximated by a line possessing a slope of 1.1. We therefore conclude that the Cy5 
dyes can be coupled to the GFP-ZE markers with near-identical efficiencies through 
sequential rounds of circuit-based labeling. 
3.4. Conclusion 
In summary, we have demonstrated that DNA circuit complexes can be used as 
erasable molecular imaging probes. Here, the sequence-dependent specificity of the DNA 
circuit reactions facilitates multiplexed marker detection. The use of strand displacement 
mechanisms also allows fluorescence reporting complexes to be disassembled, and hence, 
new reporting complexes can be created and used to image additional sets of molecular 
markers. Importantly, these reactions can be carried out at ambient temperature and in 
mild buffering conditions to minimize potential perturbations to a biological specimen. 
While such capabilities should offer opportunities to increase the number of molecular 
markers that one can examine on a single biological sample via fluorescence microscopy 
by at least a factor of 2 or 3, the next challenge will also be to develop diverse sets of 
molecular targeting agents (e.g., monovalent DNA-conjugated antibodies) that can 
facilitate efficient molecular marker recognition and react with the DNA circuitry 
reliably. Efforts to optimize syntheses of such agents are currently underway. 
Chapter 4 
Optimized On-Cell DNA Strand Exchange 
Reactions for In Situ Marker Analyses3 
This chapter provides an assessment and comparison of three different classes of 
imaging probes (probe constructs) to elucidate the contributions of complex size, free 
energy differences between states and strand displacement reactions on the labeling and 
erasing efficiencies on fixed cells. The kinetic rates of reaction of the three classes of 
imaging probes are compared to their calculated net free energy of reaction to determine 
which factor results in a more efficient and effective probe design. The chapter concludes 
with the development of an optimized dynamic nucleic acid probe system based on the 
results obtained from the characterization of the three probe constructs with short reaction 
times, non-prohibitive cost of production, highly efficient labeling and effective erasing 
steps. 
3 The content of this chapter is being prepared for publication. The following authors have 
contributed Duose D. Y, Schweller R. Moo Zimack J, Rogers A. R, Hittelman W. N and Diehl M. R. 
46 
47 
4.1. Introduction 
Recent advances in the field of DNA nanotechnology have facilitated the creation 
of various dynamic DNA and RNA complexes that can function effectively as 
programmable logic gates41 -43 , chemical amplifiers44-45, and reconfigurable molecular 
structures46• The unique potential of dynamic nucleic acid complexes for molecular-cell 
analyses are beginning to be realized. Engineered RNA hairpin devices have been used 
as 'smart' therapeutic technologies that can both detect genetic disease indicators in vitro 
and, in response, produce double stranded oligonucleotide polymers that selectively 
trigger cell apoptosis53• Multiplexed (5-color) in situ detection of mRNA transcripts in 
fixed drosophila embryos has also been demonstrated52.Yet, despite such advances; the 
translation of dynamic oligonucleotide complexes towards these types of biological 
problems remains generically challenging. Most candidate probe constructions are first 
evaluated in a test-tube where displacement reactions occur in homogenously-rnixed 
solutions62• The environment inside cells is much more complex and heterogeneous, and 
whether or not a sample is fixed and permeabilized, issues surrounding the sample 
penetration and probe dispersion must now be addressed. Other environmental factors 
may potentially interfere with the strand displacement process, and such effects could 
result in unwanted reverse or side reactions. Consequently, addressing the unique 
challenges of detecting bio-macromolecules within cells and tissues requires 
characterization of the strand exchange processes within these environments, and 
potentially, alterations to the designs of existing DNA systems to produce effective 
molecular probe systems. 
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Effective molecular probe system must meet the following design criteria; high 
specificity of targets to respective probe complexes; efficient labeling and erasing to 
ensure that fluorescent signals can be used to fully quantify target abundance without the 
interference of signals from previous rounds of labeling, and short reaction times to allow 
for multiple rounds of processing on the same sample without loss of integrity. 
Herein, we evaluate the labeling / erasing efficiencies and on-cell kinetics of three 
dynamic DNA probe constructions. Construct 1, a 3-stranded probe complex utilizes a 3-
way strand displacement mechanism for both labeling and erasing steps. Construct 2, a 2-
stranded probe complex also utilizes a 3-way strand displacement mechanism for both 
labeling and erasing steps. The third and final construct, construct 3 is a 2-stranded probe 
complex that utilizes a 3-way strand displacement labeling reaction and a 4-way strand, 
displacement erasing reaction. 
We show that efficient marker labeling and erasing is not necessarily dependent 
on the free energy differences between the different metastable states of the dynamic 
DNA complexes. Instead, non-toehold mediated strand displacement events can trigger 
reverse reactions (e.g., relabeling reactions) that reduce the overall rates that fluorophores 
can be removed from the sample. For probes that utilize a 3-way strand displacement 
mechanism, such control can be achieved via the cooperative binding of two distinct 
ssDNA components in order for a reverse reaction to occur.48 Alternatively, fluorescent 
dyes can be removed efficiently using probe designs that exchange their nuc1eotides via 
4-way strand displacement processes. As opposed to three-way systems, the erasing 
reactions with these complexes do produce inert (non-reactive) dsDNA products; the 
initiation rates of non-toehold mediated strand exchange are significantly lower. While 
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facilitating the optimization of probe designs for our application, such information should 
aid the development and implementation of other dynamic DNA systems that are 
designed for analogous future biological applications. 
4.2. Materials and Methods 
Oligonucleotides were purchased from Integrated DNA Technologies (IDT). The protein 
target, a recombinant autofluorescent protein, GFP-ZE, was produced using standard 
cloning and cell transfection procedures. The C-terrninalleucine zipper (ZE) is used as an 
affinity tag for DNA labeling. This zipper associates strongly (KD - 10-15 M) with a 
complementary basic zipper (ZR) that is incorporated into a DNA-conjugated artificial 
protein (ZR-ELS6-ssT) as a gene fusion63 . These polymers were produced according to 
the procedures presented in reference 56. The GFP-ZE offers some advantages as a 
protein target for the present study since it can be outfitted stoichiometrically with a 
single ssDNA using conjugates that are purified to homogeneity; thus, reducing problems 
that could stern from batch to batch variability associated with DNA conjugation of 
conventional protein targeting agents. 
4.2.1. DNA Probe Design 
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Probe sequences were designed using similar methods to those described in 
references 51 and 54. All sequences, excluding those taken directly from Zhang et aI., 
were selected using a custom MA TLAB script that generates random domains of 
specified lengths having pre-determined GC% range, while excluding previously 
generated domains or other prohibitive sequences (i.e. G quadruplexes), and avoiding 
secondary structures (i.e. hairpins). The generated domains (i.e toehold domains, 
specificity domains and complementary domains) are ranked according to their 
normalized two-state hybridization energies with existing probe strands using algorithms 
from mFold31 .The domains are then screened through the BLAST database64 to minimize 
sequence homology with the mRNA transcriptome. The optimal domains are then 
selected manually from this list and concatenated with other domains to create full 
oligonucleotide sequences that will be incorporated into a probe complex. Other global 
criteria such as temperature, strand concentration, salt concentration, and the 
incorporation of GC clamps are specified prior to domain design. For simplicity, the 
contributions of dyes and quencher molecules were neglected in the free energy 
calculations. 
Fluorophores (Cy3 or Cy5) and quencher molecules (Iowa Black) were 
incorporated in opposing strands at positions that minimized their intermolecular 
distance. 
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4.2.2. Cell Labeling and Erasing Procedures 
CHO cells were grown on class coverslips in DMEM supplemented with 10% FBS. 
After 24 hours, the culture medium was replaced and the cells were transiently 
transfected with vector containing the GFP-ZE construct using Fugene (Roche) according 
to the manufacturer's protocol. Cells were cultured for an additional 12 hrs to allow for 
GFP-ZE production. The cells were then fixed using freshly prepared 4% 
paraformaldehyde for 30 min. Activated aldehydes resulting from the fixation procedure 
were quenched using 1 mg/ml NaBH4 for 5 min at room temperature. Afterwards, the 
cells were permeabilized using 0.2 % Triton X-loo, washed twice with PBS, and stored 
overnight a 4 0c. 
Prior to cell labeling experiments, the coverslips were rinsed twice in PBS, dried 
under an airstream, and then affixed to custom-fabricated micro-well chambers (lO-round 
wells with 0.36 cm2 culture area and culture volume of 400Jll) using a precision-cut 
double sided adhesive film. The cells were re-hydrated with PBS before proceeding with 
labeling procedure. To minimize non-specific binding of the ZR-ELS6-ssT, cells were 
first blocked for 2 hrs using a solution containing 1 % BSA, 1 mg/ml Herring Sperm 
DNA and 0.5 uM polyT DNA in PBS. The cells were then incubated with a 400 nM 
solution of ZR-ELS6-ssT for 2 hours, and washed twice with PBS. 
GFP-ZE -labeling experiments were performed by incubating cells with solutions 
of 100 nM probe complexes in (TAE buffer supplemented with 12.5 mM Mg+2). Probe 
deactivation / erasing reactions were performed using 1 JlM of the eraser strands (Es) or 
complexes (Ec). All cell labeling / erasing reactions were carried out for 2 hours at 30°C 
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using a rotating incubator shaker (200 rpm), except for the kinetic experiments where the 
reactions were performed directly on the microscope at room temperature and without 
shaking. 
Cells were imaged using an inverted Nikon microscope outfitted with a 40x 0.9 
N.A. objective, electronic shutters, and cooled EMCCD camera (Luca; Andor). A 
mechanical transition stage and electronic focusing mechanism was used to collect 5-10 
different image fields for each sample. Images were processed using Nikon (NIS image) 
or ImageJ software32, and are presented as heat maps since this rendering enhances the 
contrast of low-level, remnant fluorescence signals within the 'erased' images. 
4.3. Results and Discussion 
4.3.1. Dynamic DNA Probe Designs 
Our previous report showed that a class of 3-strand DNA complexes (PC3s) developed 
originally by Zhang et aZ54, can function effectively as erasable molecular imaging 
probes. Yet, despite this success, we believe our application would benefit from the 
development of somewhat smaller, 2-component probe complexes that incorporate 
terminal (3' or 5') dye molecules instead of the internal dyes in our prior designs; which 
restricts the types of dyes that can be incorporated into a probe65 • To address this issue, we 
created several DNA probe complexes composed of two partially complementary DNA 
oligonucleotides (PC2s; Figure 4.1). As with the 3-strand DNA complexes (Figure 4.2), 
these probes react with their ssDNA targets (T) via toehold-mediated strand exchange to 
produce a fluorescent reporting complex (IR2) containing an unquenched fluorophore; 
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thus, molecular targets that are outfitted with their ssDNA targets can be visualized using 
fluorescent microscopy (Figures 4.3 and 4.4) . 
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Figure 4.3: Labeling and removal of Cy5 fluorophores from protein markers via 
strand displacement reactions of a 2-strand probe complex. 
(A) Selective labeling of expressed GFP proteins in CHO cells. Strong correspondence 
between the GFP and 2-strand probe (Cy5) signals is found; however, 200/0 of active Cy5 
dye remains on the cells after the erasing reaction. (B) Pixel intensities for cross section 
indicated in the Probe images for both the ON and OFF states of the cells. (C) Histogram 
of the average Cy5 signal intensities for the ON and OFF states of 20 cells, Cells are 
grouped based on their GFP fluorescence intensities as described in the methods section. 
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Figure 4.4: Labeling and removal of CyS fluorophores from protein markers via 
strand displacement reactions of a 3-strand probe complex. 
(A) Selective labeling of expressed GFP proteins in CRO cells. The OFF reactions are 
now efficient, with SIB of 1.08. This result is reflected in (B) pixel intensities for cross 
sections as well as (C) histogram of average Cy5 signal intensities for 20 cells in their 
OFF states. 
Analogously, the fluorescent reporting complexes for the 2- and 3-strand probe systems 
(IR2 and IR3 respectively) are disassembled using a single-stranded eraser oligonucleotide 
(E). Of note, the strand displacement process for the labeling and erasing reactions of 
each probe system proceed via a 3-way branched migration66, where a ssDNA component 
displaces with one oligonucleotide in a duplexed complex. 
The PC2s probes contains three distinct domains: an 18 bp domain that is 
completely hybridized (domain 1), and two 6 bp toehold domains that are positioned 
adjacent to one another at one end of the complex (domains 2* and 3*). The reporting 
complexes of the PC2s system are formed through a toehold-mediated exchange reaction 
that is initiated by hybridization of the probe complex to domain 2 of the 'target' strand. 
However, unlike the 3-strand complexes, whose reaction is completed by the release of 
an output strand from a second toehold domain (Output A and domain 3 in Figure 4.2), T 
displaces the output strand within PC2s completely. This reaction therefore results in a net 
gain of 6 matched bases within IR2 (~G = -10.14 kcal/mol). Similarly, the IR2 reporters 
are disassembled lerased via a reaction of IR with an eraser strand (E) that binds to 
toehold 3* on IR2 and displaces the T from the reporting complex. This reaction produces 
a completely duplexed waste complex (W), and yields another gain of 6 matched bases 
(~G = -8.95 kcallmol). In contrast, IR3 of the 3-strand system is disassembled I erased via 
a reaction where E binds to a 4 bp toehold, and displaces two strands (output B and T). In 
this case, T is released from the complex after it disassociates from a 6 bp toehold, and 
hence, the composite reaction of E with IR3 is energetically unfavorable (~G = + 0.33 
kcal/mol). 
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The net free energies were calculated using Nupack67 software. The free energy of 
formation of the 3-strand complex was calculated using the DNA sequences that formed 
the complex and setting the temperature, sodium and magnesium ion concentrations to 
25°C, O.05M and O.OI5M respectively in Nupack. The same criteria were used in the 
calculation of the free energies of the reporting complex, target strand, eraser strand and 
waste complex. The net free energy for labeling was calculated by subtracting the free 
energy of formation of the reporting complex from that of the substrate complex. The 
free energies of the catalyst and output strand were designed and calculated to be 0 kcal / 
mol. 
4.3.2. Selective In Situ Labeling and Erasing of DNA-conjugated Proteins 
As indicated above, both the labeling and erasing reactions of the 2-strand, PC2s, 
probes system are more thermodynamically favorable than those of the 3-strand PC3s 
probes. Thus, one may expect the PC2s probes to function as more effective, erasable 
molecular imaging probes. However, this behavior is not found in cell imaging 
experiments. Here, exogenously expressed GFP proteins within fixed and permeabilized 
CHO cells were first outfitted with 'target' strands using an ssDNA-artificial protein 
conjugate and then reacted using dynamic DNA probe complexes that incorporate Cy5 
fluorophores (Figures 4.1 and 4.2). In each case, labeling intensities were evaluated after 
the probes were allowed to react for a period of 2 hours; reactions will likely need to be 
completed within this time frame to implement our reiterative marker imaging technique. 
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Comparisons of GFP and Cy5 signals produced after a labeling reaction show that 
both the 2-strand and 3-strand probe constructs can selectively couple fluorophores to 
DNA-conjugated proteins on cells. In each case, the untransfected cells are not labeled 
and the microstructural organization and the intracellular distribution of GFP molecules 
are reproduced in the Cy5 image within the transfected cells. Near indistinguishable 
pixe1-by-pixel correlations are found between GFP and Cy5 signal intensities with both 
types of probe constructions. Yet, despite their similar performance with respect to 
protein labeling, the erasing reaction of the PC2s probe system is found to be much less 
efficient than the PC3s system (Figure 4.3). Here, the erasing reaction that disassembles 
the 2-strand IR2s reporter results in residual (Cy5) signals that are approximately 20% of 
the signal amplitudes produced by the prior marker labeling reaction. Furthermore, these 
unwanted 'OFF-state' signals are positively correlated with both the GFP levels and the 
probe-generated 'ON-state' Cy5 intensities (Figure 4.3C). This behavior is not found for 
the 3-strand complexes (Figure 4.4). As with our prior work, 'OFF-state' signals with the 
3-strand complexes can barely be detected over background autofluorescence of the slide 
(SIB =1.08). Thus, of the two different probe systems evaluated thus far, only the 3-
strand systems can function effectively as an erasable molecular imaging probe. 
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4.3.3. On-Cell Kinetics of Strand Displacement Reactions 
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Figure 4.5: Kinetics of DNA strand Displacement reactions on fixed cells 
(A) Labeling and erasing reactions of a 2-strand complex. The erasing reactions are 
inefficient and do not go down to background levels. (B) Labeling and erasing reactions 
of a 3-strand probe complex. Both the labeling and erasing reactions are efficient with the 
erasing reaction going down to background signal levels. 
We next characterized the on-cell marker labeling and erasing kinetics of the PC2s 
and PC3s systems by monitoring the rates that probe (Cy5) signals co-localized to, and 
then could be removed from, expressed GFP molecules (Figure 3.5). For these 
experiments, cells were imaged every 5 minutes during the marker labeling / erasing 
procedures. These experiments show that GFP markers are labeled rapidly by the 2-
strand probes, and that probe signals saturate within 20 min, even for the cells possessing 
the highest GFP expression levels. Although the PC3s labeling reactions were somewhat 
slower, Cy5 intensities reached their saturated values in less than 1 hour, except for the 
very brightest cells within the sample. Thus, both probe complexes can support efficient 
(relatively fast and proportionally quantitative) marker labeling. Yet, there are significant 
differences in the erasing kinetics of these systems. Although positive Cy5 fluorescence 
intensities decrease rapidly after the initial addition of E in both cases, the PC2s system 
erases more slowly than the PC3s system. In addition, and, more importantly, the PC2s 
erasing reaction slows appreciably after a period of -20 minutes, and significant Cy5 
signals (20%) remain of the sample after the full 2-hour incubation period. In contrast, 
signals in the 3-strand complexes drop rapidly to less than 3% of background signal 
levels. 
As mentioned above, given the larger free energy difference between the PC2s and 
its corresponding IR2s reporter, the labeling reaction of the 2-strand probe system is more 
energetically favorable than that of the 3-strand system. Thus, observations of higher 
labeling / 'ON' rates when PC2s is reacted with T are consistent with the differences in 
the thermodynamic properties of the different probe constructions. However, the fact that 
the erasing reaction for the 2-strand probes system is also thermodynamically favorable, 
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while the corresponding erasing reaction of the 3-strand probes is unfavorable, suggests 
that some other factor must be influencing the strand-exchange process during the erasing 
process. One possibility is that the reaction between E and 3-strand reporter IR3s produces 
a metastable intermediate complex where the fluorophore-containing strand is still 
coupled to T, but rendered inactive by the quencher. This complex could exist if T does 
not fully release from W during the erasing reaction (Figure 3.6). 
4 , 1 
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Eraser (E) 
____ ~4 ____ ~3 ____ ~1 __ ~>*. Reporting Complex (IR 3s) 
Figure 4.6: Intermediate Complex Formation during Erasing Displacement 
Reactions with a 3-strand probe complex. 
In addition, such a reaction could be thermodynamically favorable since there would be 
a gain of 4 matched bases due to the hybridization of E (domain 3) to the 3* toehold in 
I R3s . To test this, the on-cell kinetics for both the 2- and 3-strand probe complexes were 
evaluated using eraser strands that do not contain quencher molecules (Figure 4.7); thus, 
duplexed IR, other unidentified intermediate, and W complexes will still produce 
fluorescence signals if they remain bound or trapped within the cells. In this case, the 
kinetic curves measured for unquenched 3-strand erasing reaction: IR3s + E 7 W + output 
2 are very similar to the original plots in figure 4.5B. Thus, these results suggest W is 
able to release from T in this reaction, and hence, the ability for the PC3s system to erase 
efficiently is not derived from the formation of the intermediate state complex depicted in 
Figure 4.6. Furthermore, the rapid drop of Cy5 signals also indicates that the (now 
fluorescently active) W complex is 'inert' (non-reactive and unbound to T) and can freely 
diffuse out of fixed cells. 
Similarly to quencher-bearing E, the reaction of 2-strand reporter complexes IR2s 
with non-quencher bearing E leaves appreciable remnant Cy5 signals on GFP transfected 
cells due to incomplete erasing (Figure 4.7 top). However, in this case, very intense Cy5 
signals remain on the sample; 'OFF-state' pixel intensities are approximately 75 % of 
their 'ON-state" values. Of note, T does not release from the waste complex through 
toehold de-hybridization in this reaction (T is displaced completely from the complex), 
and consequently, analogous intermediate state complexes to the metastable intermediate 
depicted in Figure 3.6 are not expected to influence the PC2s system's erasing kinetics. 
While the kinetic analyses of this erasing reaction without quenchers indicate 
significant numbers of IR2s reporters remain on the cells after 2 hours, this result also 
suggests that fluorescently active W complexes are somehow bound to target and trapped 
within the cells' volume. Such behavior is somewhat surprising given the high 
concentration of E (l !AM) and reaction volume (100 !AL) used for the erasing 
experiments. With such an excess of E relative to the total number of IR2s complexes on 
the cells, there should be a strong driving force to push the erasing reaction forward. 
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Figure 4.7: Labeling and Erasing Kinetics of non -quencher bearing Eraser strand 
(Top) 2-strand complex showing about 75% residual signal (Bottom) 3-strand complex 
with low residual signal. 
However, given the compartmentalization of these targets within the cells, the local 
concentration of T and W can be quite high, which could serve to drive the reverse 
(relabeling) reaction: W + T ~ IR2s + E. Such effects could, in tum, influence the rates 
that the fluorophores within the W complexes are released from the cells since the strands 
containing the fluorophores will now transiently interact with multiple immobilized T 
strands as they diffuse towards the cell boundary. 
Interestingly, W of the PC2s system does not contain a toehold, and thus, the 
reverse / relabeling reaction must occur via a non-toehold mediated exchange process. Of 
note, these types of reactions have been shown to be enhanced when molecular crowding 
agents are present in solution68• Consequently, it is possible that proteins and other 
macromolecules within the cells act similarly and potentially also accelerate the rates of 
non-toehold mediated strand exchange. 
The observation that the W complex of the 3-strand probe system is released 
efficiently from the cells further supports the notion that reverse (relabeling) reactions 
reduce the erasing efficiencies of the 2-strand systems. In this case, two separate ssDNA 
must bind to the W complex simultaneously in order to produce the fluorescently active 
IR3s reporters. Thus, W complexes are less likely to re-associate with T and can more 
readily diffuse out of the cells. For our application, such control appears to be necessary 
to produce probes that erase efficiently while using the 3-way strand displacement 
mechanism. 
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4.3.4. Efficient Signal Erasing via Four-way Branched Migration Reactions 
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Figure 4.8: Erasing Displacement Reactions using 4-way branch migration in a 2-
strand probe complex. 
Based on the notion that non-toehold mediated exchange of oligonucleotides within 
W complexes reduces the erasing performance of the PC2s probes systems, we designed a 
simple 2-strand probe complex. This complex, will allow the use of terminal (5' or 3') 
dye molecules and quenchers, and will produce W products that are more ' inert' and can 
diffuse out of the cells more rapidly (Figure 4.8). To do so, we modified our original 2-
strand complexes such that they bind the same sequence T, but leave a second 2 bp 
toehold un-hybridized within the IR complex (domain 4 in Figure 4.8). In this case, the 
strand displacement process driving marker labeling is nearly identical to that of the 
original PC2s systems. However, the erasing reaction now proceeds via a four-way 
branched migration and exchange process69, where two different toeholds assist in the 
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initiation of the reaction. Since this reaction now produces a fully duplexed W complex, 
we anticipated that this modification would overcome the problems associated with the 
reverse (relabeling) reaction that prevents complete marker erasing in the PC2s system. 
While this system produces near identical labeling performance as the original PC2s 
probes (Figure 4.2B), and is at least as fast as the original system, the erasing step of the 
procedure is also efficient with this modification, yielding 'OFF-state' intensities and 
reaction rates that are near identical to those of the PC3s system (Figure 4.9). 
Consequently, this probe construction appears to possess all of the attributes required for 
our reiterative marker detection procedure. 
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Figure 4.9: Labeling and removal of Cy5 fluorophores from protein markers using 
the 4-way-2-strand probe complex. 
(A) Selective labeling of expressed GFP proteins in eRO cells. (B) pixel intensities for 
cross sections as well as (C) Kinetics of DNA strand displacement reactions on fixed 
cells showing the efficient labeling and erasing with 4-way-2-strand probe complex. 
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Chapter 5 
Conclusion 
This chapter provides a summary of the development and characterization of dynamic 
nucleic acid complexes as imaging probes for erasable multicolor imaging of molecular 
biomarkers in cells. The implications of the results obtained from this work and its 
applicability is discussed. The chapter concludes by providing a brief summary of results 
from on-going experiments that give new insights into the applicability of MRMBI to 
expanding the utility of immunofluorescence imaging. 
5.1. Summary and Conclusions 
The diagnosis and staging of cancer and other diseases is becoming increasingly 
reliant on the quantitative analysis of phenotypic indicators, called 'biomarkers', in 
histological samples. However, immunohistological methods remain substantially 
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restricted by the fact that only a few biomarkers can be examined on a single biological 
sample. The use of more than one specimen can circumvent this problem in some cases, 
but whenever heterogeneity across the specimens from a tissue confounds its 
characterization or is of central importance, diagnostic information is lost. The number of 
markers that can be evaluated on an individual biological sample could be increased if it 
were possible to remove fluorescent probes from cells such that new markers could be 
labeled and detected using the same fluorescent reporting molecules. However, 
fluorophores are typically attached covalently to probes that are engineered specifically 
to bind their targets with high affinity. As such, probe removal generally involves the use 
of harsh chemicals and/or physical treatments that can disrupt cell and tissue morphology 
and compromise subsequent marker analyses. 
The goal of this project was to surmount this problem by developing and 
characterizing an erasable, multi-color imaging technology capable of detecting large 
numbers of molecular markers on a single biological sample. The technology utilized 
dynamic nucleic acid complexes as probes for the selective coupling and removal of 
fluorophores to and from biomarkers via strand displacement mechanism (i.e. the 
selective exchange of single oligonucleotide strands between complexes of DNA). The 
system consisted of (1) 'targets', which are ssDNA or partially hybridized 
oligonucleotide strands conjugated to a protein of interest for biomarker recognition in 
cells, and (2) multi-strand, fluorophore-containing DNA 'probe complexes' that react 
with the DNA portion of the target in a sequence dependent fashion via a toehold 
mediated strand displacement reaction to create fluorescent reporting complexes. The 
removal of the dye (erasing step) followed via the addition of a quencher-bearing single 
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or partially hybridized DNA complex that displaced the target's DNA strand in a 
sequence specific manner to ensure efficient removal of signal without perturbing sample 
integrity. By combining dynamic DNA complexes that operate independent of one 
another with spectrally-separated dyes, multiple and unique target/probe pairs that 
associate specifically were created imaged in parallel. 
In order to successfully employ this technology for multiplexed and reiterative 
molecular biomarker imaging, the following design criteria must be met; high specificity 
of targets to respective probe complexes; efficient labeling and erasing to ensure that 
fluorescent signals can be used to fully quantify target abundance without the interference 
of signals from previous rounds of labeling, and short reaction times to allow for multiple 
rounds of processing on the same sample without loss of integrity. To meet these goals 
three classes of probes were designed and their structure-function relationships elucidated 
to determine the contributions of complex size, free energy differences between states, 
and strand displacement (toehold and non-toehold as well as 3- and 4-way) on labeling 
and erasing kinetics and efficiencies on cells. 
5.1.1. Summary of DNA Constructs Designed 
Construct 1 consisted of a ssDNA target and a partially hybridized 3-stranded 
probe complex adapted directly from Zhang et at4. This construct participated in a 3-way 
strand displacement reaction for both labeling and erasing steps. The calculated net free 
energy change was negative (-1.76 kcal/mol) for the labeling reaction and slightly 
positive (+0.33 kcal/mol) for the erasing reaction. Thus, the erasing reaction was 
expected to be slow and inefficient based solely on the net free energies. However, the 
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labeling and erasing kinetics on cells were fast and efficient. The signal to background 
ratio of the labeling step was 20: 1 whilst that of the erasing step was 1.08: 1. 
Construct 2 consisted of a ssDNA target and a partially hybridized 2-stranded 
probe complex designed in-house that also participated in a 3-way strand displacement 
reaction for both labeling and erasing steps. This construct was designed to be small 
(about half the size of construct 1), with a large negative calculated net free energy for 
both the labeling (-10.14 kcallmol) and erasing reactions (-8.95 kcallmol). Therefore, 
based on the smaller size and net free energies, this construct was expected to have a 
faster and more efficient labeling and erasing reaction rate than the previous construct. 
Surprisingly however, although the labeling kinetics on cells was fast (reaching a 
saturation level earlier than in the previous construct), the erasing kinetics was slow and 
inefficient leaving behind a substantial amount of signal after a 2hr reaction time (same 
as for the previous construct) with signal levels approximately 20% of the labeling signal. 
The inefficient removal of signal in the erasing step was attributed to non-toehold 
mediated reverse reaction that occurred because the target strand was available to 
participate in reverse reaction. 
Construct 3 consisted of a ssDNA target and a partially hybridized 2-stranded 
probe complex designed in-house that participated in a 3-way strand displacement 
labeling reaction and a 4-way strand, displacement erasing reaction resulting in the 
sequestration of the target strand making it unavailable to participate in the reverse 
reaction. This construct was designed to be small (similar in size to construct 2) to 
expedite diffusion in and out of the cell and to have a large negative net free energy for 
both the labeling (-9.98 kcal/mol) and erasing reactions (-9.07 kcal/mol). The expectation 
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for this construct was that the 4-way toehold mediated strand displacement reactions and 
sequestration of the target should speed up the erasing reaction on cells and result in a 
faster more efficient erasing step. As anticipated, the labeling and erasing kinetics on 
cells were fast and efficient with the efficiency of the erasing step similar to that of 
construct 1. 
Thus, of the three constructs characterized, construct 1 and 3 met the metrics of 
the design criteria best with construct 1 having the added advantage of an available target 
strand that can participate in multiple labeling reactions of the same molecular marker 
with minimal signal accumulation. 
This characterization showed that reaction efficiencies depend less on net free 
energy change than on the engineered state of the complex during the strand 
displacement reaction. Thus, the above characterizations provided a new paradigm for the 
optimization of dynamic nucleic acid complexes for fast and efficient erasable molecular 
biomarker imaging on a single biological sample. 
5.2. Future Directions 
5.2.1. Final probe design 
A new and final design was proposed based on the information garnered from the 
structure-function relationship of the three probe constructs. An additional criterion of 
non-prohibitive cost of production was added to the design specifications previously 
mentioned. The new probe construct consists of a partially hybridized 3-strand complex 
(with the third strand being a spectator strand that houses the quencher and serves to 
conserve quencher from construct to construct.) that participates in a 4-way strand 
displacement labeling and erasing reaction (Figure 5.1). 
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Figure 5.1: Labeling and erasing reactions using a 4 way-3-strand probe 
This structure utilizes a conserved quencher region as part of the 3-strand complex and a 
partially hybridized duplex DNA in the DNA-protein conjugate so as to increase the 
labeling reaction by participating in a 4-way strand displacement reaction in the labeling 
step. It also uses a duplexed eraser complex similar to construct 3 that reacts in a 4-way 
strand displacement reaction to remove the dye from the target while sequestering the 
target strand thus preventing it from participating in any reverse reactions or subsequent 
labeling reactions. 
Because of the conservation of quenchers in this construct, one quencher strand is 
used for both the erasing complex and the probe complex and this quencher strand is 
conserved among several different constructs with different targets thereby reducing the 
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cost associated with different quencher bearing strands for different targets. 
Consequently, barring any unforeseen complications, this design should function in a 
manner similar to that of construct 3 and all subsequent probe complexes will be 
designed according to the criteria set forth by this final construct design. Experiments are 
currently underway to determine the labeling and erasing kinetics of this final construct 
on cells. 
5.2.2. Multiplexed imaging with an antibody binding protein: LG4 
With the design and characterization of the final probe construct completed, the 
next phase of this project deals with the development of an engineered universal antibody 
binding protein that is small and has high affinity (Kd=O.24JA.M) to all antibodies7o• This 
universal antibody binding protein (protein LG), is fused to the negatively charged half of 
an engineered heterodimeric leucine zipper complex56 to create a protein LG-zipper 
construct (LG-ZE). This construct can then interact with the target portion of the dynamic 
DNA complex through association with the positively charged leucine zipper conjugated 
to the DNA (ZR-ELS6-DNA). The resulting protein LG-zipper-zipper-DNA ({LG-ZE } -
{ZR-ELS6-DNA}) construct can then be bound to any antibody of interest while 
maintaining probe complex specificity through the target's DNA sequence. To detect 
several markers on the same biological sample, individual antibodies are pre-bound to a 
4 The data and information provided here for multiplexed imaging with antibody binding protein: LG 
is the work of Arthur Rogers PhD 
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specific protein LG-zipper-zipper-DNA complex in solution to form antibody-protein 
LG-zipper-zipper-DNA complex. This is to ensure that antibody-DNA complexes are 
formed stoichiometrically before being incubated on cells, so as to reduce crosstalk 
between antibodies and protein LG. Through this process, several different targets 
(ssDNA) can be self assembled with antibody-protein LG-zipper constructs as shown in 
Figure 5.2. 
I 
I 
Figure 5.2: Scheme showing the self-assembly of leucine zipper -protein LG with 
ZR-ELS6-DNA and antibodies. 
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A 
B 
c 
Figure 5.3: Comparison of immunofluorescence image of labeled MT 
(A) protein LG-DNA complex without microtubule-antibody (B) primary microtubule-
antibody and dye labeled secondary (C) protein LG-DNA complex with primary 
microtubule-antibody. All images were taken at 500ms exposure and contrasted the same. 
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Preliminary data from this endeavor is illustrated in Figure 5.3, where the labeling 
efficiency of microtubule with antibody associated to the protein LG-zipper-zipper DNA 
complex is shown to be qualitatively comparable to that of an indirect 
immunofluorescence labeling of the microtubules with primary and secondary antibodies. 
It is worthy to note that a control experiment with only the protein LG-zipper-zipper 
DNA complex (no antibody was associated to this complex) produced no signal implying 
low binding of protein LG to cells. Therefore this information provides preliminary 
evidence that a universal antibody binding protein (LG) can be used to image biomarkers 
in cells. Further experiments are still needed to ensure that minimum crosstalk occurs 
when multiple antibodies are used in a single labeling reaction. 
5.2.3. Amplification 
With the establishment of the self assembled antibody constructs in place, 
markers with low signal levels could be detected using dynamic DNA probe complexes 
with antigen recognition capabilities coupled with signal amplification. This signal 
amplification can be achieved based on the same strand displacement principle. Various 
dynamic DNA complex technologies can be integrated with the current probe design to 
achieve signal amplification. One such technology, Hybridization Chain Reaction 
(HCR)44, can be integrated into the 3-strand probe construct to achieve signal 
amplification. 
The HCR technology utilizes small DNA hairpins as substrates in a linear 
polymerization reaction (Fig. 5.4). Polymerization is triggered by the presence of a 
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specific ssDNA strand called the initiator. This reaction then produces a long linear 
polymer possessing multiple nicked duplexes. 
c a* 
b* + 
c* 
Figure 5.4: Hybridization chain reaction mechanism 
The addition of the initiator to both hairpins triggers the formation of higher order 
polymers (the amplified product). 
L1 L2 L3 L4 
L 1: Substrate 1 
(alone) 
L2: Substrate 2 
(non-complementary 
amplification circuit) 
L3: Substrate 1 
( complementary 
amplification circuit) 
L4: Substrate 1 
(with amplification, then 
deamplification) 
Figure 5.5: Native PAGE-gel showing the selective amplification and de-
amplification (L4) of 3-strand probe construct via the HeR method. 
L3 shows higher molecular weight products formed as a result of amplification. 
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Preliminary solution phase data in figure 5.5 shows that the addition of both 
hairpin strands to an initiator bearing 3-strand construct (substrate 1) resulted in the 
formation of higher order polymers (amplification) on the 3-strand construct. The 
addition of both hairpins to a non-initiator bearing 3strand construct (substrate 2) did not 
result in the formation of higher order polymers. This preliminary data shows that 
amplification schemes can be incorporated into MRMBI probes for detection of low level 
signals on cells and tissues. Further experiments are still needed to ensure that 
incorporation of signal amplification meets the design criteria ofMRMBI probes. 
Finally, with the development and characterization of an optimized probe design 
for multiplexed and reiterative molecular biomarker imaging completed, the development 
of signal amplification schemes and of methods through which these probes can be easily 
conjugated to ligands (proteins, antibodies, mRNA, aptamers etc) that recognize 
biomarkers of interest will increase the diagnostic power of individual histological 
specimens and open the door to more sophisticated analyses of cell phenotype and its 
functional relationship to disease. 
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Appendix A 
Table l:List of oligonucleotide sequences used indesign of DNA-circuits 
Underlined oligonucleotides denote toehold domains. All strands are listed in 5' to 3' 
direction. /3AmMC6/ denotes a 3' amino modifier on carbon 6; /5Cy5/ denotes 5' cy5 
fluorophore; /5Cy3/ denotes 5' cy3 fluorophore and /3IAbRQSp/ denotes 3'Iowa black 
quencher. 
Sequence Name Nucleic Acid Sequence 
Circuitl_Ol CCA CAT ACA TCA TAT TCC CTC ATT CAA TAC CCT ACG/3IAbRQSp/ 
CircuitL02 CTT TCC TAC A CC TAC GTC TCC AAC TAA CTT ACGG 
CircuitLLB TGG AGA /iCy5/CGT AGG GTA TTG AAT GAG GGC CGT AAG TTA GTT GGA GAC GTA GG 
CircuitLC CAT TCA ATA CCC TAC GTC TCC ATT TTT TTT TT 
'3AmMC6/ 
CircuitLFuel CCT ACG TCT CCA ACT AAC TTA CGG CCC TCA TTC AAT ACC CTA CG/3IAbRQSp/ 
CircuitLOl comp GTA TTGAATGAGGGAATATGATGT ATGTGG 
Circuitl Olshort CCA CAT ACA TCA TAT TCC CTC ATT 
Circuit2_ 01 ACC TCT TCA CGA ACA TTT CAl3IAbRQSp/ 
Circuit2_02 ACC TAA TAG C AC CAC ATC AAT CTC GAT CCA 
GTAC 
Circuit2_LB TGG CTA /iCy3/TGA AAT GTT CGT GAA GAG GTG 
rrAC TGG ATC GAG ATT GAT GTG GT 
Circuit2_C CTT CAC GAA CAT TTC ATA GCC ATT TTT TTT TT 
1/3AmMC6/ 
Circuit2_Fuel ACC ACA TCA ATC TCG ATC CAG TAC ACC TCT 
[rCA CGA ACA TTT CA 
Circuit2 Olcomp TGT TCG TGA AGA GGT 
Circuit2_ ° 1 short ACCTCTTCA 
Circuit3_0l TCA CAC ATC AAC CTC T TCTT T CTC TCG ACA 
~ATCAC 
Circuit3_02 CTT TCC TAC A CT TAT TCA TCC TTT CAC TCA CTT 
~ 
Circuit3 _LB GAA GTG AGT GAA AGG ATG AAT AAG AAG AGTG 
~TG TGT CGA GAG AAAG TAA 
87 
Circuit3_C TCT CTC GAC ACA TCA C TTA CTT TT TTT TTT TT 
1'3 AmMC61 
Circuit3 _Fuel CT TAT TCA TCC TTT CAC TCA CTT CTCTT TCT 
~TC GAC ACA TCA C 
Circuit3 Olcomp TGT CGA GAG AAA GAA GAG GTT GAT GTG TGA 
Circuit3 ° 1 short TCA CAC ATC AAC CTC TTC TTT CTC 
Circuit4_SB CAC CAA CCC AAT TCT C CCTA C CCA TTC CTG 
[fAT CAT 
Circuit4_0B ACC TAA TAG C TAC CTT CCC TCT ATT CAT GTC 
tAC 
Circuit4_LB GTG GAC ATG AAT AGA GGG AAG GTATAG GATG 
lATA CAG GAA TGG GTGG AGT 
Circuit4_C CCC ATT CCT GTA TCA T AC TCC A TT TTT TTT TT 
1'3AmMC61 
Circuit4_Fuel TAC CTT CCC TCT ATT CAT GTC CAC CCT ACC CAT 
[fCC TGT ATC AT 
Circuit4 ° 1 comp CAG GAA TGG GTA GGG AGA ATT GGG TTG GTG 
Circuit4 Olshort CAC CAA CCC AAT TCT C CCTA C CCA 
CircuitS_Ol CAT ACC ACA ACA ATT TAC TTC ACC AAC CCA 
[fCC ACT 
CircuitS_02 CTT TCC TAC AAA TCG CCA AAC TAC AAA CTC 
AATC 
CircuitS _LB GAG GTG AGT GGA TGG GTT GGT GAA GTG ATT 
GAG TTT GTA GTT TGG CGA TT 
CircuitS_C CAC CAA CCC ATC CAC TCA CCT C TT TTT TTT TT 
'3AmMC61 
CircuitS _Fuel AAT CGC CAA ACT ACA AAC TCA ATC ACTT CAC 
CAA CCC ATC CAC T 
CircuitS Olcomp TOO GTT OOT GAA GTA AAT TGT TGT GGT ATG 
CircuitS Olshort CAT ACC ACA ACA ATT TAC TTC ACC 
lcompcyS ISCyS/TGT AGG AAA G 
88 
